The Rosen Law Firm Announces Investigation of Jiangbo Pharmaceuticals, Inc.
June 16 2011 - 11:26PM
Business Wire
The Rosen Law Firm, P.A. announces that it is investigating
potential securities claims against Jiangbo Pharmaceuticals, Inc.
(NASDAQ: JGBO) resulting from allegations that the company may have
issued materially misleading statements and business information to
the investing public.
The Rosen Law Firm is investigating the circumstances
surrounding the resignation of certain of the Company’s personnel
and the Company’s internal investigation. These adverse events
appear to have prompted the halt in trading of the Company’s common
stock since May 31, 2011.
The Rosen Law Firm is preparing a securities class action
lawsuit on behalf of Jiangbo Pharmaceuticals investors to recover
their investment losses. If you purchased Jiangbo stock, please
visit the website at http://rosenlegal.com to participate in the
class action and to obtain more information. You may also contact
Phillip Kim of The Rosen Law Firm toll free at 866-767-3653 or via
e-mail at pkim@rosenlegal.com.
The Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar
outcome.